RheumNow

Curbside Consults - February 2016

Save

By Jack Cush, MD

23 February 2016

The following is a collection of cases presented to me by rheumatology colleagues. Each has a challenging therapeutic or safety issue. Answers are based on experience with references from literature and guidelines.

Read Article

Challenges of Dermatomyositis Progress

Save

By Jack Cush, MD

23 February 2016

In the current issue of Lancet, Pierre Miossec discusses the challenges of studying and managing juvenile dermatomyositis and, specifically, the

Read Article

Transdermal NSAID Touted as an Advance

Save

By Jack Cush, MD

23 February 2016

Reuters reports that researchers at the University of Warwick have devised a new transdermal drug delivery patch that may change the future of pain management.

Read Article

Febuxostat Safe in Gout with Moderate-Severe Renal Impairment

Save

By Jack Cush, MD

22 February 2016

Renal impairment is a risk factor for gout and a barrier to optimal gout management. Many of the drugs used to treat gout require adjustment in those with renal disease.

Read Article

Pulmonary Hypertension Earlier and More Severe in Men with Scleroderma

Save

By Jack Cush, MD

22 February 2016

Pulmonary hypertension is an uncommon complication of systemic sclerosis (SSc) and historically thought to slowly evolve in those with limited scleroderma over many years.

Read Article

Only Two-Thirds of US Adults Get Adequate Sleep

Save

By Jack Cush, MD

22 February 2016

Optimal sleep duration for adults is suppose to be 7 or more hours of sleep each night. Shorter sleep duration (7 hours per night) is associated with greater likelihoods of obesity, high blood pressure, diabetes, coronary heart disease, stroke, frequent mental distress, and death.

Read Article